Guilherme Caldas Emrich
Président chez BIOMM S.A.
Fortune : 16 M $ au 30/04/2024
Profil
Mr. Guilherme Caldas Emrich is Chairman at Centro de Inovações CSEM Brasil, Founding Partner at FIR Capital Partners - Gestão de Investimentos SA, and Chairman at BIOMM SA. He is on the Board of Directors at Oncoclínicas do Brasil Serviços Médicos SA.
He received his undergraduate degree from Universidade Federal de Minas Gerais.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BIOMM SA
3,17% | 30/11/2022 | 4 020 123 ( 3,17% ) | 16 M $ | 30/04/2024 |
Postes actifs de Guilherme Caldas Emrich
Sociétés | Poste | Début |
---|---|---|
BIOMM S.A. | Président | 16/12/2013 |
FIR Capital Partners - Gestão de Investimentos SA
FIR Capital Partners - Gestão de Investimentos SA Investment ManagersFinance FIR Capital Partners - Gestão de Investimentos (FIR Capital) is the Brazil-based venture capital arm of Draper Fisher Jurvetson in the US. The firm was founded by Guilherme Emrich and Marcus Regueira in 1999 to invest in innovative start-up, emerging or growing companies with significant growth potential. Headquartered in Belo Horizonte, FIR Capital became a subsidiary of Draper Fisher Jurvetson in 2007. They pursue investments where they can add value, making direct investments and investing through funds in world-class companies with the potential for exponential growth. Their flagship fund, Fundotec I, was one of the first venture capital funds in Brazil. | Fondateur | 19/07/2011 |
Fundação Dom Cabral | Directeur/Membre du Conseil | - |
Government of Brazil | Corporate Officer/Principal | - |
Anciens postes connus de Guilherme Caldas Emrich
Sociétés | Poste | Fin |
---|---|---|
Biobras SA
Biobras SA Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Biobras SA is a Brazilian company that manufactures diabetes products. The company is based in Montes Claros, Brazil. The company was founded by Guilherme Caldas Emrich. Biobras was acquired by Novo Nordisk A/S on November 19, 2002 for $15.70 million. | Fondateur | 01/01/2002 |
Fundação Biominas | Président | 01/02/1999 |
Oninn Centro de Inovacoes
Oninn Centro de Inovacoes Miscellaneous Commercial ServicesCommercial Services Oninn Centro de Inovacoes provides research and development services. It develops and industrializes technologies transforming basic research into applied products in the areas of nanotechnology, microtechnology, systems engineering, telecom and information technology. The company was founded by Guilherme Caldas Emrich in 2006 and is headquartered in Belo Horizonte, Brazil. | Fondateur | - |
ONCS BRAS | Directeur/Membre du Conseil | - |
Formation de Guilherme Caldas Emrich
Universidade Federal de Minas Gerais | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BIOMM S.A. | Health Technology |
ONCS BRAS | Health Services |
Entreprise privées | 5 |
---|---|
FIR Capital Partners - Gestão de Investimentos SA
FIR Capital Partners - Gestão de Investimentos SA Investment ManagersFinance FIR Capital Partners - Gestão de Investimentos (FIR Capital) is the Brazil-based venture capital arm of Draper Fisher Jurvetson in the US. The firm was founded by Guilherme Emrich and Marcus Regueira in 1999 to invest in innovative start-up, emerging or growing companies with significant growth potential. Headquartered in Belo Horizonte, FIR Capital became a subsidiary of Draper Fisher Jurvetson in 2007. They pursue investments where they can add value, making direct investments and investing through funds in world-class companies with the potential for exponential growth. Their flagship fund, Fundotec I, was one of the first venture capital funds in Brazil. | Finance |
Oninn Centro de Inovacoes
Oninn Centro de Inovacoes Miscellaneous Commercial ServicesCommercial Services Oninn Centro de Inovacoes provides research and development services. It develops and industrializes technologies transforming basic research into applied products in the areas of nanotechnology, microtechnology, systems engineering, telecom and information technology. The company was founded by Guilherme Caldas Emrich in 2006 and is headquartered in Belo Horizonte, Brazil. | Commercial Services |
Fundação Biominas | |
Biobras SA
Biobras SA Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Biobras SA is a Brazilian company that manufactures diabetes products. The company is based in Montes Claros, Brazil. The company was founded by Guilherme Caldas Emrich. Biobras was acquired by Novo Nordisk A/S on November 19, 2002 for $15.70 million. | Health Technology |
Government of Brazil | Government |